Balzer BWR, Duke SA, Hawke CI, Steinbeck KS. The effects of estradiol on mood and behavior in human female adolescents: a systematic review. Eur J Pediatr. 2015;174:289–98.

Article  CAS  PubMed  Google Scholar 

Klipker K, Wrzus C, Rauers A, Boker SM, Riediger M. Within-person changes in salivary testosterone and physical characteristics of puberty predict boys’ daily affect. Horm Behav. 2017;95:22–32.

Article  CAS  PubMed  Google Scholar 

Gordon JL, Sander B. The role of estradiol fluctuation in the pathophysiology of perimenopausal depression: a hypothesis paper. Psychoneuroendocrinology. 2021;133:105418.

Article  CAS  PubMed  Google Scholar 

Hantsoo L, Payne JL. Towards understanding the biology of premenstrual dysphoric disorder: from genes to GABA. Neurosci Biobehav Rev. 2023;149:105168.

Article  CAS  PubMed  Google Scholar 

Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, et al. 5α-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology. 2016;41:1093–102.

Article  CAS  PubMed  Google Scholar 

Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012;169:465–75.

Article  PubMed  PubMed Central  Google Scholar 

Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women’s health. Epidemiol Rev. 1995;17:265–86.

Article  CAS  PubMed  Google Scholar 

Howards PP, Schisterman EF, Wactawski-Wende J, Reschke JE, Frazer AA, Hovey KM. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle study. Am J Epidemiol. 2009;169:105–12.

Article  PubMed  Google Scholar 

Mumford SL, Schisterman EF, Gaskins AJ, Pollack AZ, Perkins NJ, Whitcomb BW, et al. Realignment and multiple imputation of longitudinal data: an application to menstrual cycle data. Paediatr Perinat Epidemiol. 2011;25:448–59.

Article  PubMed  PubMed Central  Google Scholar 

Taylor AE, Keevil B, Huhtaniemi IT. Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur J Endocrinol. 2015;173:D1–12.

Article  CAS  PubMed  Google Scholar 

Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9:41–9.

Article  CAS  PubMed  Google Scholar 

Hamidovic A, Soumare F, Naveed A, Davis J, Sun J, Dang N. Reduced dehydroepiandrosterone-sulfate levels in the mid-luteal subphase of the menstrual cycle: implications to women’s health research. Metabolites. 2022;12:941.

Article  CAS  PubMed  PubMed Central  Google Scholar 

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [Internet]. Fifth Edition. American Psychiatric Association; [cited 2024 Mar 14]. Available from: https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596. 2013.

Dubey N, Hoffman JF, Schuebel K, Yuan Q, Martinez PE, Nieman LK, et al. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Mol Psychiatry. 2017;22:1172–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marrocco J, Einhorn NR, Petty GH, Li H, Dubey N, Hoffman J, et al. Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back. Mol Psychiatry. 2020;25:572–83.

Article  CAS  PubMed  Google Scholar 

Li HJ, Goff A, Rudzinskas SA, Jung Y, Dubey N, Hoffman J, et al. Altered estradiol-dependent cellular Ca2+ homeostasis and endoplasmic reticulum stress response in Premenstrual Dysphoric Disorder. Mol Psychiatry. 2021;26:6963–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamidovic A, Davis J, Soumare F, Naveed A, Ghani Y, Semiz S, et al. Allopregnanolone is associated with a stress-induced reduction of heart rate variability in premenstrual dysphoric disorder. J Clin Med. 2023;12:1553.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH. Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res. 1999;830:72–87.

Article  CAS  PubMed  Google Scholar 

Carver CM, Reddy DS. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology. 2013;230:151–88.

Article  CAS  PubMed  Google Scholar 

Nguyen TV, Reuter JM, Gaikwad NW, Rotroff DM, Kucera HR, Motsinger-Reif A, et al. The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback. Transl Psychiatry. 2017;7:e1193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiesner J, Granger DA. A lack of consistent evidence for cortisol dysregulation in premenstrual syndrome/premenstrual dysphoric disorder. Psychoneuroendocrinology. 2016;65:149–64.

Article  PubMed  Google Scholar 

Schmidt PJ, Martinez PE, Nieman LK, Koziol DE, Thompson KD, Schenkel L, et al. Premenstrual dysphoric disorder symptoms following ovarian suppression: triggered by change in ovarian steroid levels but not continuous stable levels. Am J Psychiatry. 2017;174:980–9.

Article  PubMed  PubMed Central  Google Scholar 

Segebladh B, Borgström A, Nyberg S, Bixo M, Sundström-Poromaa I. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol. 2009;201:139.e1–8.

Article  PubMed  Google Scholar 

Sun BZ, Kangarloo T, Adams JM, Sluss P, Chandler DW, Zava DT, et al. The relationship between progesterone, sleep, and LH and FSH secretory dynamics in early postmenarchal girls. J Clin Endocrinol Metab. 2019;104:2184–94.

Article  PubMed  PubMed Central  Google Scholar 

McCartney CR, Gingrich MB, Hu Y, Evans WS, Marshall JC. Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone. J Clin Endocrinol Metab. 2002;87:2194–200.

Article  CAS  PubMed  Google Scholar 

Reid RL. Premenstrual Dysphoric Disorder (Formerly Premenstrual Syndrome). In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279045/ 2024.

Gallo MA, Smith SS. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav. 1993;46:897–904.

Article  CAS  PubMed  Google Scholar 

Saavedra M, Contreras CM, Azamar-Arizmendi G, Hernández-Lozano M. Differential progesterone effects on defensive burying and forced swimming tests depending upon a gradual decrease or an abrupt suppression schedules. Pharmacol Biochem Behav. 2006;83:130–5.

Article  CAS  PubMed  Google Scholar 

Contreras CM, Azamar-Arizmendi G, Saavedra M, Hernández-Lozano M. A five-day gradual reduction regimen of chlormadinone reduces premenstrual anxiety and depression: a pilot study. Arch Med Res. 2006;37:907–13.

Article  CAS  PubMed  Google Scholar 

Lovick TA, Guapo VG, Anselmo-Franci JA, Loureiro CM, Faleiros MCM, Del Ben CM, et al. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology. 2017;75:83–90.

Article  CAS  PubMed  Google Scholar 

Ney LJ, Felmingham KL, Nichols D. Reproducibility of saliva progesterone measured by immunoassay compared to liquid chromatography mass spectrometry. Anal Biochem. 2020;610:113984.

Article  CAS  PubMed  Google Scholar 

Sundström-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone - friend or foe? Front Neuroendocrinol. 2020;59:100856.

Article  PubMed  Google Scholar 

Mesen TB, Young SL. Progesterone and the luteal phase: a requisite to reproduction. Obstet Gynecol Clin North Am. 2015;42:135–51.

Article  PubMed  PubMed Central  Google Scholar 

Bixo M, Andersson A, Winblad B, Purdy RH, Bäckström T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 1997;764:173–8.

Article  CAS  PubMed  Google Scholar 

Bethea CL, Reddy AP, Tokuyama Y, Henderson JA, Lima FB. Protective actions of ovarian hormones in the serotonin system of macaques. Front Neuroendocrinol. 2009;30:212–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sundström I, Bäckström T. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry. 1998;44:755–64.

Article  PubMed